Jasper Therapeutics Inc (JSPR)
20.40
-0.78
(-3.68%)
USD |
NASDAQ |
Apr 26, 16:00
20.26
-0.14
(-0.69%)
After-Hours: 20:00
Jasper Therapeutics Cash from Investing (TTM): -0.267M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.267M |
| September 30, 2023 | -0.119M |
| June 30, 2023 | -0.341M |
| March 31, 2023 | -0.573M |
| December 31, 2022 | -0.576M |
| Date | Value |
|---|---|
| September 30, 2022 | -1.205M |
| June 30, 2022 | -1.453M |
| March 31, 2022 | -1.497M |
| December 31, 2021 | -2.428M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.428M
Minimum
Dec 2021
-0.119M
Maximum
Sep 2023
-0.9399M
Average
-0.576M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -502.52M |
| Equillium Inc | -4.762M |
| Akero Therapeutics Inc | -223.62M |
| 89bio Inc | -123.02M |
| PepGen Inc | -32.00M |